baber/WOPTO huggingface dataset:
Patent AU-2006311433-B2 (AU)
Title: Alpha-helix mimetics and method relating to the treatment of cancer stem cells
Inventor: KAHN MICHAEL
IPC: A61K31/4985
Filed: 2006-11-08
Granted: 2012-06-28
Abstract: The invention provides alpha -mimetic structure of formula (I) wherein A is -(C=O)-CHR-, or -(C=O), B is N-R- or -CHR-, D is -(C=O)-(CHR)- or - (C=O) E is -(ZR)- or (C=O), G is -(XR)n-, -(CHR)-(NR)-, -(C=O)-(XR)-, -(C=N-W-R)-, -(C=O)-, X-(C=O)-R, X-(C=O)-NRR, X-(SO)-R, or X-(C=O)-OR, W is -Y(C=O)-, -(C=O)NH-, -(SO)-, -CHR, (C=O)-(NR)-, substituted or unsubstituted oxadiazole, substituted or unsubstituted triazole, substituted or unsubstituted thiadiazole, substituted or unsubstituted 4,5 dihydrooxazole, substituted or unsubstituted 4,5 dihydrothiazole, substituted or unsubstituted 4,5 dihydroimidazole, or nothing, Y is oxygen or sulfur, X and Z is independently nitrogen or CH, n=0 or 1; and R R, R, R, R, R, R, R, R R, R, R, R, R, and R are the same or different and independently selected from an amino acid side chain moiety or derivative thereof, the remainder of the molecule, a linker and a solid support, and stereoisomers, salts, and prodrugs thereof, provided that where B is CHR and W is -Y(C=O)-, -(C=O)NH-, -(SO), -CHR, or (C=O)-(NR)-, G cannot be CHR, NR, (C=O)-CHR, (C=O)-NR, or no atom at all. Additionally, the invention provides methods wherein α-mimetic compounds are used to treat cancer stem cells
Patent AU-2006311458-B2 (AU)
Title: Compositions and methods for the treatment of addiction and other neuropsychiatric disorders
Inventor: GOEDERS NICHOLAS E
IPC: A61K31/4985
Filed: 2006-11-13
Granted: 2012-05-10
Abstract: The present invention is based, in part, on our discovery that certain types of therapeutic agents can be used in combination to treat a variety of neuropsychiatric and related disorders, including addiction (e.g., to a substance or to an activity) as well as to alleviate some of the symptoms experienced during menopause or associated with the menstrual cycle. Regardless of the precise formulation, the compositions of the invention can include at least one active ingredient that targets the hypothalamo- pituitary-adrenal (HPA) axis and at least one active ingredient that targets the prefrontal cortex. Either or both of these types of agents can be combined with an agent that inhibits activity in the sympathetic nervous system. Thus, the compositions or combination pharmacotherapies can also include an agent that inhibits a beta-adrenergic receptor or that otherwise acts as an anti-hypertensive or anxiolytic agent.
Patent AU-2007213932-B2 (AU)
Title: Gun rivet
Inventor: STROBEL MARCEL
IPC: B21J15/02
Filed: 2007-02-12
Granted: 2012-11-22
Abstract: The invention relates to a gun rivet and a device for placing said rivet. The gun rivet contains a rivet head (1) with a collar (3) at one end and a rivet tip (6) at the other. The rivet body contains a cavity (7) in the form of a bore in a sleeve section (22). As with other gun rivets, the gun rivet is shot with a percussive-type action and with the aid of its rivet tip into an opening in two sheets (13, 14) that are to be joined together, until the collar comes to rest on the upper face of the upper sheet. A tensile bolt is then introduced into the cavity and is connected to the base (8) of the latter. This can be achieved by resistance welding. The tensile bolt is then drawn until a rivet head is formed on the opposite side of the two sheets. The tensile bolt is then detached from the gun rivet, for example by shearing. The tensile bolt can be re-used to place another rivet.
Patent AU-2007253124-B2 (AU)
Title: Ball bearing cage
Inventor: ADANE THIERRY
IPC: F16C33/41
Filed: 2007-04-12
Granted: 2012-02-02
Abstract: Ball bearing cage (4) consisting of a bead ring (7) and a substantially axial portion (8) fitted with claws (11) that define alveolus (9) for balls and joining on the bead (7), the substantially axial portion (8) stretching axially on one portion of the alveolus (9). The substantially axial portion (8) presents an external diameter inferior to the external diameter of the bead (7), the external diameter of the substantially axial portion being comprised between the primitive diameter of the cage reduced to half of the radial thickness of the diameter of the bead and the primitive diameter increased to half of the radial thickness of the bead.
Patent AU-2007337794-B2 (AU)
Title: Metal oxide scaffolds
Inventor: ELLINGSEN JAN EIRIK
IPC: A61L27/02
Filed: 2007-12-21
Granted: 2012-12-20
Abstract: The present invention relates to a metal oxid scaffold comprising titanium oxide. The scaffolds of the invention are useful for implantation into a subject for tissue regeneration and for providing a framework for cell growth and stabilization to the regenerating tissue. The invention also relates to methods for producing such metal oxide scaffolds and their uses.
Patent AU-2008201989-B2 (AU)
Title: Method of Detecting and Treating Tuberous Sclerosis Complex Associated Disorders
Inventor: GOULD-ROTHBERG BONNIE
IPC: C07K14/47
Filed: 2008-05-06
Granted: 2012-05-31
Abstract: Disclosed are methods of detecting and treating tuberous sclerosis complex associated 5 disorders. Also disclosed are methods of identifying agents for treating tuberous sclerosis complex associated disorders.
Patent AU-2008202816-B2 (AU)
Title: Block valve for vacuum line or network with emergency input
Inventor: DENEUX PATRICK
IPC: A61M39/22
Filed: 2008-06-25
Granted: 2011-03-31
Abstract: The valve (1) has a control device (5) e.g. manually controlled on/off ball valve, arranged on a main passage (2) and comprising a handle that is manually operated by an operator and moved between an open position and a closed position. The control device allows fluid communication between two orifices in the open position, and interrupts the fluid communication between the orifices in the closed position. An auxiliary passage is connected to the main passage provided between the control device and one of the orifices through an upstream end of the auxiliary passage that has third orifice.
Patent AU-2008241091-B2 (AU)
Title: Quinoline-carboxamide derivatives as P2Y12 antagonists
Inventor: JUST MELITTA
IPC: C07D401/12
Filed: 2008-04-09
Granted: 2013-05-09
Abstract: The present invention relates to compounds of the Formula (I), in which R
Patent AU-2008258141-B2 (AU)
Title: Polycarboxy emulsion copolymer binder compositions
Inventor: KELLY MICHAEL DEWAYNE
IPC: D04H1/587
Filed: 2008-12-15
Granted: 2014-04-10
Abstract: The present invention provides flexible binder compositions comprising one or more polycarboxy emulsion copolymer has a measured Tg of 40*C or less, such as from -45*C to 25*C, and a polyol crosslinker. In one embodiment, the binder compositions comprising the polycarboxy emulsion copolymer can be used in making pultruded composites, such as sheets, for example, flexible gypsum board facing sheets, and flexible non-woven articles such as, for example, carpet backing.
Patent AU-2008265103-B2 (AU)
Title: FFE media and FFE methods comprising volatile separation media
Inventor: WEBER GERHARD
IPC: G01N27/447
Filed: 2008-06-20
Granted: 2014-05-22
Abstract: The present invention provides methods and separation media for separating analytes of interest via free flow electrophoresis (FFE) using volatile buffer systems. The separation media provided herein allow a convenient separation of the analytes by electrophoresis, and offer the additional advantage that the buffer compounds and the solvent can be easily and residue-free removed after the electrophoretic separation step. Furthermore, methods for mass spectrometric analysis of analytes comprising an FFE method and kits for carrying out FFE separations with volatile buffer systems are also provided. Preferably, the volatile buffer system is TRIS acetate.
Patent AU-2008303975-B2 (AU)
Title: (Cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
Inventor: BARTOSCHEK STEFAN
IPC: A61P25/28
Filed: 2008-09-04
Granted: 2013-05-16
Abstract: The invention relates to (cyclopropyl-phenyl)-phenyl-oxalamides and the physiologically compatible salts thereof. The invention also relates to compounds of formula (I), wherein Rl, R2, R3, R4, R5, R6, R7, R8 and m have the cited designations, and to the physiologically compatible salts thereof. The compounds are suitable, for example, for the treatment of diabetes.
Patent AU-2008305793-B2 (AU)
Title: Claylinked polymer gels in new physical forms, methods for their formation and uses thereof
Inventor: KORNER ANNA
IPC: B01J20/26
Filed: 2008-09-25
Granted: 2012-10-04
Abstract: The invention provides a fibre, film or foam comprising a plasticizer and a charged claylinked gel (A), said charged claylinked gel (A) comprising clay nanoparticles (C) which are crosslinked by a charged polymer (A') such that any particular clay nanoparticle is linked to at least one other clay nanoparticle by said charged polymer (A'). Methods for producing the fibres, film and foam are also provided.
Patent AU-2008312470-B2 (AU)
Title: Continual flow pin washer
Inventor: BUKYS ALBERT
IPC: B08B3/02
Filed: 2008-10-16
Granted: 2013-07-11
Abstract: A multi-chambered deposition pin wash station is provided. The wash station includes a lower chamber and an upper drain basin connected by a plurality of wash tubes. Cleaning fluid is provided to the lower chamber and passes through the cleaning tubes into the upper drain basin. The cleaning tubes are adapted to clean a single deposition pin with a single tube per wash cycle.
Patent AU-2008335252-B2 (AU)
Title: Detection of time of arrival of CDMA signals in a wireless location system
Inventor: ANDERSON ROBERT J
IPC: G01S5/06
Filed: 2008-12-09
Granted: 2011-11-10
Abstract: In a Wireless Location System (WLS) deployed in connection with a CDMA-based wireless communications system, Location Measurement Units are used to collect multi-path corrupted radio signaling for use in time difference of arrival (TDOA) and hybrid positioning methods. Signal processing techniques are used to enhance the WLS's ability to determine the minimally time- delayed multi-path component and thus increase the accuracy of the TDOA location in CDMA-based wireless communications systems. The signal processing includes a filtering technique for reducing the leading sidelobes of the cross-correlation function as well as a leading edge discovery procedure.
Patent AU-2008335715-B2 (AU)
Title: Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
Inventor: FRANCIS DANIEL
IPC: A61N5/02
Filed: 2008-12-12
Granted: 2014-01-23
Abstract: The present invention is directed to systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy. In one embodiment of the invention a medical device and associated apparatus and procedures are used to treat dermatological conditions using microwave energy.
Patent AU-2008346922-B2 (AU)
Title: Control valve trim and seal
Inventor: FLEMING LESLIE E
IPC: F16K47/08
Filed: 2008-12-11
Granted: 2015-01-15
Abstract: A fluid control device comprises a valve body (12), a valve plug (16), a valve cage (18,20), and a sealing ring (21). At least a portion of the sealing ring (21) is disposed within a gap (74) between the valve plug (16)and the valve cage (18, 20) to provide a seal therebetween when the valve plug (16) is in the closed position. The sealing ring (21) includes an L-shaped cross-section that provides an effective seal regardless of the port diameter of the fluid control device, and thus, reduces the number of types of seals required to be stored in inventory for various applications.
Patent AU-2009200362-B2 (AU)
Title: Immunosuppressant compounds and compositions
Inventor: GRAY NATHANAEL S
IPC: C07D413/10
Filed: 2009-02-02
Granted: 2011-12-01
Abstract: 5 The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
Patent AU-2009207467-B2 (AU)
Title: Improvements in belt seams
Inventor: COGHLAN STEPHEN MARK
IPC: F16G3/04
Filed: 2009-01-13
Granted: 2013-03-28
Abstract: A clipper seam (13) for joining the ends (11, 12) of a belt (10), are connected by interdigitated staples (15, 16) which are looped about a pintle (14) and provide (barbs 17) on their remote ends to penetrate into the material of the belt. Each end (11, 12) is covered by an edge strip (18, 19) of vinyl by radio frequency welding, and a flap is attached to one end (12) on the low pressure side (40) of the belt by a (portion 20), and folded over to cover the seam on the low pressure side by means of a (flap 22) which extends beyond the seam area of the other end (11). A central area (25) to each side of the seam is impregnated with polyurethane to resist abrasion which tends to concentrate in this area.
Patent AU-2009212565-B2 (AU)
Title: Automatic control system for ceiling fan based on temperature differentials
Inventor: TOY MARK
IPC: F24F11/76
Filed: 2009-02-03
Granted: 2013-09-05
Abstract: A fan includes a hub, several fan blades, and a motor that is operable to drive the hub. A motor controller is in communication with the motor, and is configured to select the rate of rotation at which the motor drives the hub. The fan is installed in a place having a floor and a ceiling. An upper temperature sensor is positioned near the ceiling. A lower temperature sensor is positioned near the floor. The temperature sensors communicate with the motor controller, which includes a processor configured to compare substantially contemporaneous temperature readings from the upper and lower temperature sensors. The motor controller is thus configured to automatically control the fan motor to minimize the differences between substantially contemporaneous temperature readings from the upper and lower temperature sensors. The fan system may thus substantially destratify air in an environment, to provide a substantially uniform temperature distribution within the environment.
Patent AU-2009247782-B2 (AU)
Title: Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (N-methylcarbamoylmethyl) piperidin- 4-yl] oxy } quinazoline
Inventor: WHITLOCK BRIAN
IPC: A61P35/00
Filed: 2009-05-11
Granted: 2012-06-28
Abstract: 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline difumarate, pharmaceutical compositions containing the difumarate, the use of the difumarate in the treatment of hyperproliferative disorders such as cancer and processes for the manufacture of the difumarate are described.
Patent AU-2009251272-B2 (AU)
Title: Minimally-invasive methods for implanting obesity treatment devices
Inventor: MAKOWER JOSHUA
IPC: A61B17/34
Filed: 2009-05-28
Granted: 2012-01-19
Abstract: Tools, devices and methods for treating a patient. An incision or puncture is made though the patient's skin and a delivery tract is made through an opening formed by the incision or puncture, subcutaneous fat and fascia, far into the patient's abdominal cavity. A guide member is inserted through the delivery tract and a distal end portion of the guide member is positioned at a target location within the abdominal cavity. An implantable device is delivered with the aid of the guide member, and the implantable device is attached to at least one internal body structure. A fillable member of the implantable device is at least partially filled with fluid. The guide member is removed and an adjustment member is attached to a conduit in fluid communication with the fillable member. The attachment member is anchored to an internal body structure and the incision or puncture is closed.
Patent AU-2009253623-B2 (AU)
Title: A soluble tumor necrosis factor receptor mutant
Inventor: WU FANG
IPC: C12N15/12
Filed: 2009-01-12
Granted: 2013-08-22
Abstract: A soluble tumor necrosis factor receptor 2 (TNFRII) mutant has an amino acid substitution at position 92Glu compared with the wild TNFRII. The mutant improves the cytotoxicity capacity of neutralizing TNFalpha and lymphotoxin. The mutant and fusion protein comprising it are useful for the treatment of TNFalpha or lymphotoxin related diseases.
Patent AU-2009257142-B2 (AU)
Title: Rack and pinion drive for by-pass cartridge
Inventor: MACDONALD DANIEL
IPC: B01F15/02
Filed: 2009-06-10
Granted: 2014-07-03
Abstract: A device for mixing a substance comprised of two constituents contained in a cartridge (12) and having a cartridge holder (32) thereabout, the device comprising a plunger rod (46) for pushing a closure member (20) to permit the transfer of a diluent in a second chamber (28) through a by-pass channel (24) to mix with a constituent in a first chamber (26), the plunger rod (48) being driven by means of a rack (48) and a pinion gear (50) arrangement to prevent overly rapid movement of the plunger rod (46).
Patent AU-2009263944-B2 (AU)
Title: A user interface for monitoring the status of medical machines
Inventor: STEFANINI MICHELE
IPC: G16H40/40
Filed: 2009-05-14
Granted: 2013-03-21
Abstract: A user interface for monitoring the status of medical machines includes a display which shows data coming from a processing unit relating to parameters of the machines. The processing unit comprises means for establishing to which operating status of the medical machines the data belongs to. The processing unit determines if a medical machine is in correct functioning status; if a medical machine is in a warning status; or if a machine is in critical status. Means generate synthetic data characterised using colours according to whether the medical machine is in the correct functioning, the warning or the critical status.
Patent AU-2009265657-B2 (AU)
Title: An apparatus for applying traction to a penis
Inventor: MULLER JES BECH
IPC: A61F5/41
Filed: 2009-07-03
Granted: 2015-01-22
Abstract: An apparatus (1) for applying traction to a penis, comprising a base member (10), a glans' retaining member (20) and a telescoping connection member (30 is disclosed.
Patent AU-2009295191-B2 (AU)
Title: Child safe door, frame and hinge assembly
Inventor: BOYER GEORGE AKOS
IPC: E06B7/36
Filed: 2009-09-21
Granted: 2016-06-30
Abstract: A door, frame and hinge assembly (10) includes a door (12) having a main body (24) with a hinge side defined by a convexly curved surface (14), and a frame (16, 70, 76) having a hinge side defined by a door jamb cavity (26). A hinge means (22) connects the hinge side of the door (12) to the hinge side of the frame (16, 70, 76) through a hinge pivot point (45). The convexly curved surface (14) extends beyond the location of the hinge pivot point (45) towards, and locates within, the cavity (26), so as to allow the door (12) to open without a gap being created between the hinge side of the door and the frame that may cause finger-pinch injury. The convexly curved surface (14) may be the curved surface of a cylindrical quarter segment (14a). The hinge side of the door (12) is formed integrally or continuously with the main body (24) of the door and extends into the door jamb cavity (26). The cavity (26) is defined at one side by the doorstop face (20) of a hinge side door jamb (16) and at the opposite side by a stationary wing (44) of the hinge means, with an innermost side of the cavity being defined by a hinge side wall stud (70).
Patent AU-2009304096-B2 (AU)
Title: Method for reducing the pulp content of fruit juices containing pulp
Inventor: PECORONI STEFAN
IPC: B04B11/02
Filed: 2009-10-07
Granted: 2014-09-18
Abstract: The invention relates to a method for reducing the pulp content of fruit juices, particularly citrus juices, containing pulp, wherein the fruit juice is continuously purified of a pulp phase in the centrifugal field of a separator (3), said pulp phase being drawn from the separator drum through a fluid discharge, characterized in that the density of the pulp phase drawn from the separator is measured using a density flow-through measuring device (14) and that according to said density measurement at least one controllable device (15, 17) is controlled. The density of the pulp phase can be influenced by the control of said device.
Patent AU-2009313402-B2 (AU)
Title: Automatically switching different aspiration levels and/or pumps to an ocular probe
Inventor: RANEY ROB
IPC: A61M1/00
Filed: 2009-11-06
Granted: 2015-04-23
Abstract: Methods and apparatuses for automatically switching different aspiration levels to an ocular probe are disclosed herein. The probe may be a phacoemulsification prober A first aspiration level, supplied by a-first pump,-roay-be- applϊed-to the-probe simultaneously with ultrasonic energy. A second aspiration level, supplied by a second pump, may be automatically switched from the first aspiration level. Control feed back of the pumps may be varied according to set thresholds.
Patent AU-2009313873-B2 (AU)
Title: Selective drug delivery in a lumen
Inventor: PERRY MIKE
IPC: A61F2/958
Filed: 2009-11-13
Granted: 2015-03-12
Abstract: Methods and systems are disclosed for selective drug or fluid delivery in a lumen through a coating or fluid delivery channels. One system includes an elongate catheter having a proximal end and a distal end with an axis therebetween, the catheter having a radially expandable balloon near the distal end and an energy delivery portion proximate the balloon for transmission of energy, a thermally changeable coating having a releasable drug coupled to the balloon, the thermally changeable coating being oriented to be urged against the body tissue when the expandable balloon expands and an energy source operatively coupled to the energy delivery portion configured to energize the energy delivery portion to heat and liquefy the thermally changeable coating to release the drug to the body tissue.
Patent AU-2010201473-B2 (AU)
Title: IMS Application Server, Network, Method, and Computer Program Product for Executing Services, Particularly IP Contact Center Services
Inventor: SILVIA TENENTI
IPC: H04L29/12
Filed: 2010-04-14
Granted: 2011-11-24
Abstract: The present description is directed to an IMS application server, an IMS network, a computer-implemented method, and a computer program product for 5 executing services, such as IP Contact Center services, accessible over a plurality of different access channels. The IMS application server for executing services accessible over a plurality of different access channels may include a service creation layer operable to provide components for creating at least one service, testing the at least one service and deploying the at least one service into a service execution layer, 10 and said service execution layer including service logic components operable to execute the at least one service, and communication components operable to connect to at least one external service involved in executing the at least one service. [Figs. 9A and 9B] 14/04/10ct. 18484.specification as filed. 14-apr-10,3
Patent AU-2010212083-B2 (AU)
Title: Automatic coffee maker with sensor for detecting the quantity of coffee in the machine
Inventor: POZZARI STEFANO
IPC: A47J31/42
Filed: 2010-02-05
Granted: 2015-06-25
Abstract: The machine comprises: a brewing unit (3); a water reservoir (7); a boiler (11) for the production of hot water to supply to the brewing unit; a coffee container (13); an electronic control unit (27); a user interface (33). At least one capacitive sensor (31) is associated to the coffee container to detect the quantity of residual coffee in the container (13). The sensor is connected to the electronic control unit, which is programmed to supply to a user by means of the interface at least a piece of information regarding the quantity of coffee in said container.